Infographic.pdf (551.2 kB)
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons
media
posted on 2024-06-26, 16:04 authored by AdisRapid Journals on behalf of:, Walter Reinisch, Gil Y. Melmed, Hiroshi Nakase, Jakob Seidelin, Christopher Ma, Si Xuan, Jacinda Tran, Valencia Remple, Lani Wegrzyn, Gweneth Levy, Yuri Sanchez Gonzalez, Remo Panaccione
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above interactive infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
